the aid library

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- Conflict
- Zika
- TB
- Cholera
- HIV
- Polio
- Rapid Response
- Refugee
- Disability
- Specific Hazards
- Social Ethics
- Health Financing Toolbox

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Key
Resources

Clinical
Guidelines

Women & Child
Health

Pharmacy &
Technologies

English

English Deutsch Español Français русский عربى

My MEDBOX Register

Login
Register
English
- English
- Deutsch
- Español
- Français
- русский
- عربى

Search database

Create your MEDBOX

LIST OPTIONS

Filter

Filtered Results: 46

Text search: Pitt C.

Featured

New Publications

Language

English

German

Spanish

French

Russian

Document type

No document type

Studies & Reports

Manuals

Guidelines

Countries / Regions

Global

Nigeria

Nepal

Tanzania

Cameroon

Côte d’Ivoire / Ivory Coast

Ethiopia

Uganda

Zimbabwe

Haiti

Zambia

Kenya

Rwanda

South Africa

Malawi

Eswatini/ Swaziland

Colombia

Lesotho

Authors & Publishers

BMJ Global Health

Pitt, C.

Central Asian Journal of Global Health

Federal Ministry of Health, Nigeria

H. Zainiddinov

Lancet

Martinez-Alvarez, M.

N. Habibov

National Agency for the Control of AIDS (NACA)

UNAIDS

World Health Organization

A. Chu, Z. Li et al.

A. Gheorghe

Achary A.

Agudelo Calderón,C.

Alimonte, Mary D'

ALNAP, Provention Consortium

Arregoces L. et al.

Arregoces, L.

Bath, D.

Bauersachs, J.

Berliner, D.

Binyaruka, P.

BJOG An International Journal of Obstetics and Gynaecology

BMA

Borghi, J.

British Medical Journal (BMJ)

Buendía, J.

C. Grollman

C. Pitt

C. Pitt et al.

Carmen de Witt-Amrein

Challenge TB

Clift, Jack

Dahab M.

Deutsches Ärzteblatt International

Diabetes & Metabolism Journal

Erziehungsdirektion Kanton Bern, Amt für Kindergarten, Volksschule und Beratung (AKVB)

et al

et al.

F. Daly

F. Federspiel

Fabienne Heiniger

Fishel, Joy D., Ruilin Ren, Bernard Barrère, and Trevor N. Croft

Flatten, G., Gast, U., Hofmann, A., Knaevelsrud, C., Lampe, A., Lieberman, P., Maercker, A., Reddemann, L. & Wöller, W.

G. Greco

G. Greco et al.

Geldsetzer, P.

Global Health Action

Graves C. et al.

Grollman C.

Hannah Bowen

Hänselmann, A.

Health Affairs

Health Policy and Planning

Hitzeroth, J.

Hoviyeh Afnan-Holmes, Moke Magoma, Theopista John, et al.

Hsu, J.

J. E. Lawn

K. Hauck

Kang Yiu Lai, Wing Yiu George Ng and Fan Fanny Cheng

Kate Kerber, Stefan Peterson & Peter Waiswa

Kinder- und Jugendpsychiatrie/-psychotherapie, Universitätsklinikum Ulm

Klug, E. et al.

KNV

Lancet Glob Health

Larson, E.

LeMier, Ryan

Li Z., Richter L., Lu C.

Lu, C.

M. Martínez-Álvarez et al.

M. Ranganathan et al.

Malaria No More

Martinez-Alvarez M.

Martinez-Alvarez M. et al

Maryland, USA: ICF International

Mboggo, E.

Meershoek A, Zwerling A, Daftary A, Citro B, Smyth C, Lewis D

Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.

Ministerio de la Protección Social, Colombia

Mpe, M.

N. Singh et al.

National Agency for the Control of AIDS (NACA), Government of Nigeria

Nomura S. et al.

Oswald, S. H., Ernst, C., Goldbeck, L.

Pardo, R.

Park, J.J.

Patel P.

Paudel, D., Shrestha, I.B., Siebeck, M. & Rehfuess, E.A.

Pitt C.

Pitt1, C.

PLoS Med

PLOS One

Pradhan, Y.V., Upreti, S.R., Pratap, K.C.N, et al.

Pubmed

Quirk, E.J.

Regula Buchli

Results for Development (R4D)

Royal Pharmaceutical Society, etal.

T. Powell-Jackson et al.

Tanabe M. et al.

Thacher, Emily

The Dutch Music Therapy Association (NVvMT) & European Music Therapy Confederation (EMTC)

The Lancet

The South African Medical Journal

Trauma & Gewalt

UKE Hamburg

University of Pittsburgh

USAID

World Health Organisation (WHO)

World Health Organization WHO

Publication Years

1990-1999

2000-2009

2010-2019

2020-2025

Traumatische Erlebnisse bei Kindern: Diagnostik und Psycho-Edukation

Regula Buchli; Carmen de Witt-Amrein; Fabienne Heiniger Erziehungsdirektion Kanton Bern, Amt für Kindergarten, Volksschule und Beratung (AKVB) (2017) C2

Die aktuelle weltpolitische Lage führt dazu, dass immer mehr potentiell traumatisierte Kinder der Unterstützung von Fachleuten – auch in der psychologischen Grundversorgung - bedürfen. Traumata können bei Kindern aber auch durch Hospitalisationen und damit verbundene medizinische Eingriffe, Un...fälle o.ä. ausgeloest werden, wie im Folgenden beschrieben wird. Die Diagnose von Traumafolgestörungen bei Kindern ist durch die Tatsache erschwert, dass sie eine Reihe unspezifischer und altersabhängiger Symptome zeigen, die auch bei anderen Störungen auftreten, was unter Umständen zu Fehldiagnosen (ADHS) führen kann. Aus diesem Grund hat die vorliegende Arbeit zum Ziel, Fachpersonen eine Zusammenstellung grundlegender Informationen zur Entstehung und Diagnostik von Traumafolgestörungen sowie einen Überblick über gängige Diagnoseinstrumente zur Verfügung zu stellen. more

Add to my MEDBOX

BNF for Children 2019-2020

BMA; Royal Pharmaceutical Society, etal. (2020) C2

External Link

Add to my MEDBOX

Equity of resource flows for reproductive, maternal, newborn, and child health: are those most in need being left behind?

Martinez-Alvarez, M.; F. Federspiel; N. Singh et al. British Medical Journal (BMJ) (2020) CC

Since 2002 the distribution of external funding to reproductive, maternal, newborn, and child health (RMNCH) has become more equitable and better targeted at the poorest countries and those experiencing the highest mortality. The aid envelope is not large enough or well enough concentrated to close ...gaps in domestic government fund ing between the poorest and middle income countries. Donors and governments of low and middle income countries should increase their investments for RMNCH . Donors should further concentrate their funds on the poorest countries and those with the highest maternal, newborn, and child mortality. Investment is also needed to close serious data and methodological gaps for assessing equity of financing between and within countries more

Add to my MEDBOX

2020 Heart Failure Society of South Africa perspective on the 2016 European Society of Cardiology Chronic Heart Failure Guidelines

Hitzeroth, J.; Mpe, M.; Klug, E. et al. The South African Medical Journal (2020) CC

Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...reatment of acute and chronic heart failure published in 2016, and summarises what is considered the best current management of patients with the condition. It provides information on the definition, diagnosis and epidemiology of HFrEF in the African context. The best evidence-based treatments for HFrEF are discussed, including established therapies (beta-blockers, ACE-i/ARBs, mineralocorticoid receptor antagonists (MRAs), diuretics) that form the cornerstone of heart failure management as well as therapies that have only recently entered clinical use (angiotensin receptor-neprilysin inhibitor (ARNI), sodium/glucose cotransporter-2 (SGLT2) inhibitors). Guidance is offered in terms of more invasive therapies (revascularisation, implantable cardioverter defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) by implantation of a biventricular pacemaker with (CRT-D) or without (CRT-P) an ICD, left ventricular assist device (LVAD) use and heart transplantation) in order to ensure efficient use of these expensive treatment modalities in a resourcelimited environment. Furthermore, additional therapies (digoxin, hydralazine and nitrates, ivabradine, iron supplementation) are discussed and advice is provided on general preventive strategies (vaccinations). Sections to discuss conditions that are particularly prevalent in sub-Saharan Africa (HIV-associated cardiomyopathy (CMO), peripartum CMO, rheumatic heart disease, atrial fibrillation) have been added to further improve clinical care for these commonly encountered disease processes. more

External Link

Add to my MEDBOX

The Treatment of Heart Failure with Reduced Ejection Fraction

Berliner, D.; Hänselmann, A.; Bauersachs, J. Deutsches Ärzteblatt International (2020) CC

Background Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death. Methods This review is based on articles retrieved by a selective search in PubMed, as well as on r...elevant guidelines. Results Evidence-based treatment options are available only for congestive heart failure with a low ejection fraction. Pharmacotherapy is based on neurohumoral inhibition of the renin-angiotensin-aldosterone system and the adrenergic system. The prognosis of patients with this condition has been further improved recently through the introduction of combined angiotensin receptor antagonists and neprilysin inhibitors. Modern implantable devices are a further component of treatment. Implantable defibrillators and special pacemakers for cardiac resynchronization are well established; the utility of alternative devices (baroreflex modulation or cardiac contractility modulation) needs to be investigated in further studies. It was recently shown that the catheter-based treatment of secondary mitral regurgitation with a MitraClip improves the outcome of selected patients. Conclusion The treatment of chronic systolic heart failure as recommended in the relevant guidelines, with drugs and implanted devices if indicated, can significantly improve the clinical outcome. more

Download (71)

View PDF (52)

Add to my MEDBOX

Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes

Park, J.J. Diabetes & Metabolism Journal (2021) CC

The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients wit...h DM have a worse prognosis than those without DM. Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyperglycemia, hyperinsulinemia, and insulin resistance can cause alterations in vascular homeostasis. Then, reduced nitric oxide and increased reactive oxygen species levels favor inflammation leading to atherothrombotic progression and myocardial dysfunction. The classification, diagnosis, and treatment of HF for a patient with and without DM remain the same. Until now, drugs targeting neurohumoral and metabolic pathways improved mortality and morbidity in HF with reduced ejection fraction (HFrEF). Therefore, all HFrEF patients should receive guideline-directed medical therapy. By contrast, drugs modulating neurohumoral activity did not improve survival in HF with preserved ejection fraction (HFpEF) patients. Trials investigating whether sodium-glucose cotransporter-2 inhibitors are effective in HFpEF are on-going. This review will summarize the epidemiology, pathophysiology, and treatment of HF in diabetes. more

Create your own MEDBOX
Login

Home
Contact
Data privacy
Legal notice
FAQ
About
Sitemap

A Project by

dev-medbox @ 2025